Einstein/Montefiore Department of Medicine

In The Media

The Associated Press highlights a recent study by Michael Alderman, M.D., about new ways to treat hypertension that might help optimize patient care. The study found that measuring blood levels of the hormone renin may assist doctors in determining which blood pressure medicine their patients should take. The research also found that in some cases taking a drug that's a poor match to that hormone can actually trigger a spike in blood pressure. Dr. Alderman is professor of epidemiology & population health and of medicine and the Atran Foundation Chair in Social Medicine. (Tuesday, September 07, 2010)

Dr. Alderman's Profile
The Wall Street Journal features news of a study by Michael Alderman, M.D. which aims to help provide scientific guidelines to help doctors prescribe appropriate medication for high blood pressure. Doctors have known for years that patients with different physical characteristics respond differently to various hypertension drugs. Dr. Alderman's study focused on using the hormone renin as a biomarker for matching the correct drugs to the individual patient. Dr. Alderman is professor of epidemiology & population health and of medicine and the Atran Foundation Chair in Social Medicine. (Tuesday, August 24, 2010)

Dr. Alderman's profile
CNN features comments from Chaim Putterman, M.D., on why women may experience chronic pain more intensely than men. He notes that a woman's hormones may influence the severity of pain. Though men and women deal with pain differently, many doctors treat them the same for conditions such as rheumatoid arthritis. He also notes the correlation between chronic pain and depression and the need to treat both issues simultaneously to improve quality of life in patients living with chronic pain conditions. Dr. Putterman is chief of the division of rheumatology and professor of medicine and of microbiology & immunology. (Friday, August 13, 2010)

Dr. Putterman's Profile
The New York Times interviews Nir Barzilai, M.D., about a new study published in Science that identifies a set of 150 genetic variants that predicts extreme longevity with 77 percent accuracy. Dr. Barzilai notes that these genes provide protection against all the diseases of old age, a more powerful strategy than tackling each disease one by one. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Professor of Aging Research and director of Einstein's Institute for Aging Research. (Thursday, July 01, 2010)

Dr. Barzilai's Profile
U.S. News & World Report (via Science News) features Jill Crandall, M.D., and her pilot study, which indicates that resveratrol, the substance widely known to be found in red wine and thought to impart health benefits, improves insulin resistance. Dr. Crandall emphasized that while the results of her small study were promising, they are preliminary and the benefits of resveratrol remain unproven. Dr. Crandall is associate professor of clinical medicine. (Tuesday, June 29, 2010)

Dr. Crandall's profile
CNN.com interviews Dr. Alyson Moadel on new recommendations for cancer patients to be as physically active as possible both during and after their treatment. Dr. Moadel emphasizes the need for patients to choose an activity they enjoy, which increases the likelihood they will adhere to a fitness program. Dr. Moadel is associate professor of clinical epidemiology & population health at Einstein and director of the psychosocial oncology program at the Albert Einstein Cancer Center. (Monday, June 14, 2010)

Dr. Moadel's Profile
The Daily Telegraph (UK) interviews Nir Barzilai, M.D., on his research with centenarians and their genetic make-up, which allows many of them to lead "unhealthy" lifestyles and still live to 100. Dr. Barzilai notes that those who live extraordinarily long lives are genetically protected from the effects of environmental factors, like smoking and a poor diet. He is in the UK to address the Royal Society in London on aging and treating age-related diseases. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Professor of Aging Research and director of the Institute for Aging Research. (Tuesday, May 11, 2010)

Dr. Barzilai's Profile
Science interviews Michael Alderman, M.D., about a new Institute of Medicine report that recommends the FDA require food manufacturers restrict added salt in their foods. Dr. Alderman argues that current and new salt-intake recommendations are not based on sound science and may have unintended consequences on public health. Dr. Alderman is professor of medicine and of epidemiology & population health and the Atran Foundation Chair in Social Medicine. (Friday, April 23, 2010)

Dr. Alderman's Profile
Los Angeles Times interviews Judith Wylie-Rosett, Ed.D., about a JAMA study that found that the consumption of added sugars, on the rise in the U.S., affects blood lipids in a way that increases the risk of heart disease. Dr. Wylie-Rosett notes that one of the reasons added sugars are so abundant in the American diet is that high fructose corn syrup is plentiful and cheap, and food manufacturers rely on it to make their products tastier. Dr. Wylie-Rosett is head of the division of health, behavior & nutrition at Einstein, and professor of epidemiology & population health. (Wednesday, April 21, 2010)

Dr. Wylie-Rosett's Profile
The Associated Press interviews David Prezant, M.D., senior author, and Thomas Aldrich, M.D., lead author, on their study that investigates the lung health of 9/11 rescue workers. The research, published in The New England Journal of Medicine, was led by Einstein and Montefiore Medical Center, in collaboration with the Fire Department of New York City (FDNY). The study of nearly 13,000 FDNY rescue workers demonstrates that the significant proportion who suffered acute lung damage after exposure to World Trade Center dust have not recovered normal lung function since 2001. Drs. Prezant and Aldrich are both professors of medicine at Einstein and attending physicians in the pulmonary medicine division at Montefiore. Dr. Prezant is also chief medical officer at the FDNY. (Thursday, April 08, 2010)

Dr. Prezant's Profile | Dr. Aldrich's Profile
The New York Times interviews Meredith Hawkins, M.D., on the results of a clinical trial which showed that an aspirin-like drug helped patients manage their type 2 diabetes. Dr. Hawkins notes that the trial, which tested a generic anti-inflammatory drug from the aspirin family, demonstrated that inflammation is a good target for treating diabetes and has been a topic of discussion among endocrinologists for a long time. Dr. Hawkins is director of the Global Diabetes Initiative and professor of medicine. (Tuesday, March 16, 2010)

Dr. Hawkins' Profile
The Associated Press features research by Preeti Kishore, M.B.B.S., which proposes a mechanism linking obesity and poor health. Dr. Kishore's lab infused the blood of overweight but otherwise healthy volunteers with free fatty acids, which are found in elevated levels in obese individuals. Their bodies immediately stopped responding effectively to insulin. Additionally, the infusions triggered certain immune cells to overproduce PAI-1, an inflammatory protein that has previously been linked to insulin resistance, heart disease and diabetes. The report was published in Science Translational Medicine. Dr. Kishore is assistant professor of medicine. (Tuesday, March 02, 2010)

Dr. Kishore's profile
The New York Times interviews Michal Melamed, M.D., on a new five-year clinical trial that will study the impact vitamin D and fish oil supplements have on lowering the risk for cancer and heart disease. Dr. Melamed points out that while estimates show that many Americans are vitamin D deficient, studies have not yet determined the risks of having too much vitamin D in the system. Dr. Melamed is assistant professor of medicine and of epidemiology & population health. (Tuesday, February 02, 2010)

Dr. Melamed's Profile
The Daily Mail (UK) profiles Nir Barzilai, M.D., his discovery of the first human "longevity genes," and the new BBC documentary featuring his research and its treatment implications. BBC Horizon interviews Dr. Barzilai, who discusses his work and new medications developed based on it, which are intended to provide protection against age-related diseases and extend life span. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Professor of Aging Research and director of the Institute for Aging Research. (Tuesday, February 02, 2010)

Dr. Barzilai's Profile
UPI features research by Mary E. Fabry, Ph.D., and Eric E. Bouhassira, Ph.D., which identifies a potential new treatment for thalassemia, a debilitating type of inherited anemia that affects millions of people worldwide. Their study in mice, published in Nature Medicine, also found that the treatment would address the iron overload that accompanies the lifelong transfusions often used to treat the disease. Dr. Fabry is professor of medicine and Dr. Bouhassira is the Ingeborg and Ira Leon Rennert Professor of Stem Cell Biology and Regenerative Medicine. (Thursday, January 28, 2010)

Dr. Fabry's profile | Dr. Bouhassira's profile
First Page | Previous Page | Page of 10 | Next Page | Last Page
Click here to log in